Terumo Corporation has agreed to acquire Sequent Medical for $380m.

Of the total, $280m will be paid upon closing of the agreement and the remaining will be paid upon achieving specific commercial and development milestones.

The acquisition will help Terumo to establish and expand its growth in the neurovascular market.

Trelleborg has signed an agreement to buy Specialty Silicone Fabricators (SSF), a high-precision silicone components manufacturer for medical technology original equipment manufacturers (OEMs).

To be completed by the end of this month, the acquisition will will enable Trelleborg to strengthen its position in the life sciences market.

“The acquisition will will enable Trelleborg to strengthen its position in the life sciences market.”

Searchlight Pharma has purchased Besins Healthcare Canada, an exclusive Canadian supplier of Mona Lisa copper intrauterine devices (IUDs).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

New women’s healthcare products, which will complement Searchlight’s existing portfolio, will be added by the former, through the acquisition.

FluoroPharma Medical has signed a non-binding letter of intent to acquire Ground Fluor Pharmaceuticals, a medical imaging products company.

The deal will complement FluoroPharma Medical’s late-stage positron emission tomography (PET) imaging assets for the treatment of heart disease, cancer and degenerative neurological conditions.

Fukuda Denshi has signed a memorandum of understanding (MOU) to acquire Omron Colin from Omron Healthcare for $18.69m.

Through the acquisition, Fukuda Denshi will form a business partnership with the Omron Healthcare in home medical care and overseas business, while Omron will focus on the development of devices.

Upon completion of the acquisition, Omron Colin will become the subsidiary of Fukuda Denshi, which then will get access to the Omron’s products such as vital signs monitors and medical examination equipment.